Executive leadership
Skip Kiil
Executive Vice President & President, Cardiovascular Portfolio
Harry “Skip” Kiil is Executive Vice President and President of Medtronic’s Cardiovascular Portfolio. He serves on the Medtronic Executive Committee and leads a global team focused on delivering transformative therapies across six operating units – Cardiac Ablation Solutions, Cardiac Rhythm Management, Cardiac Surgery, Coronary & Renal Denervation, Mechanical Circulatory Support, Peripheral Vascular Health, and Structural Heart and Aortic.
Skip has more than 20 years of global leadership experience in the medical technology industry. He is known for building high-performing teams, leading complex business transformations, and driving strong commercial and operational execution.
Prior to this role, Skip served as president of Medtronic’s Cranial & Spinal Technologies (CST) Operating Unit, where he led the business to record growth and helped establish CST as a $5 billion global leader. He was the architect of CST’s AiBLE™ strategy—a connected ecosystem of technology, data, and services that is redefining surgical care in spine and cranial procedures.
Before joining Medtronic, Skip held senior leadership roles at Smith+Nephew, NuVasive, Novartis, and Stryker. His experience spans global commercial operations, product innovation, manufacturing, and go-to-market strategy. He has led teams across the U.S., Europe, and Asia, with a focus on execution, accountability, and culture.
He is also deeply committed to improving access to care. During his time in CST, Skip launched a strategic partnership with Hall of Fame Health to expand access to specialized neurosurgical and spinal care for former athletes, U.S. veterans, and their families. While at Smith+Nephew, he helped initiate a similar partnership focused on expanding access to joint replacement care. These efforts reflect his broader commitment to closing care gaps and improving health equity through innovative industry collaboration.
Skip holds a Bachelor of Science in Kinesiology from California State University, Fullerton, and an MBA from the University of Michigan Ross School of Business.
